BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38473833)

  • 41. Effects of massage on the expression of proangiogenic markers in rat skin.
    Ratajczak-Wielgomas K; Kassolik K; Grzegrzolka J; Halski T; Piotrowska A; Mieszala K; Wilk I; Podhorska-Okolow M; Dziegiel P; Andrzejewski W
    Folia Histochem Cytobiol; 2018; 1(2):83-91. PubMed ID: 29770958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis.
    Cavallaro U; Tenan M; Castelli V; Perilli A; Maggiano N; Van Meir EG; Montesano R; Soria MR; Pepper MS
    J Cell Biochem; 2001; 82(4):619-33. PubMed ID: 11500940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain gliomas and growth factors: immunohistochemical, immunofluorescence, flow cytometry and RT-PCR profile in pediatric age.
    Taurone S; Spoletini M; Chiappetta C; Di Gioia C; Carletti R; Greco A; Agostinelli E; Ralli M; Giangaspero F; Artico M; Pastore FS; Scarpa S; Gobbi P; Di Liddo R
    J Biol Regul Homeost Agents; 2019 September-October,; 33(5):1451-1463. PubMed ID: 31507151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL).
    Demacq C; Vasconcellos VB; Izidoro-Toledo TC; da Silva Silveira V; Canalle R; Queiroz RG; Tone LG; Tanus-Santos JE
    Clin Chim Acta; 2010 Sep; 411(17-18):1335-40. PubMed ID: 20510681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification of angiogenesis stimulators in children with solid malignancies.
    Pavlakovic H; Von Schütz V; Rössler J; Koscielniak E; Havers W; Schweigerer L
    Int J Cancer; 2001 Jun; 92(5):756-60. PubMed ID: 11340583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF).
    Jung S; Wermker K; Poetschik H; Ziebura T; Kleinheinz J
    Head Face Med; 2010 Dec; 6():29. PubMed ID: 21176170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.
    Dmoszyńska A; Bojarska-Junak A; Domański D; Roliński J; Hus M; Soroka-Wojtaszko M
    Leuk Lymphoma; 2002 Feb; 43(2):401-6. PubMed ID: 11999576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree.
    Parsons-Wingerter P; Elliott KE; Clark JI; Farr AG
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1250-6. PubMed ID: 10807740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
    Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
    Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular endothelial growth factor levels in childhood acute lymphoblastic and myeloblastic leukemia.
    Leblebisatan G; Antmen B; Saşmaz I; Kilinç Y
    Indian J Hematol Blood Transfus; 2012 Mar; 28(1):24-8. PubMed ID: 23449155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of acid-base balance and high or low intensity exercise on VEGF and bFGF.
    Wahl P; Zinner C; Achtzehn S; Behringer M; Bloch W; Mester J
    Eur J Appl Physiol; 2011 Jul; 111(7):1405-13. PubMed ID: 21161264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growth factor--the characteristics and function].
    Mizia-Malarz A; Sobol G; Woś H
    Przegl Lek; 2008; 65(7-8):353-7. PubMed ID: 19004235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
    Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1.
    Couper LL; Bryant SR; Eldrup-Jørgensen J; Bredenberg CE; Lindner V
    Circ Res; 1997 Dec; 81(6):932-9. PubMed ID: 9400373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells.
    Mentlein R; Eichler O; Forstreuter F; Held-Feindt J
    Int J Cancer; 2001 May; 92(4):545-50. PubMed ID: 11304689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.